Getting care on Mind and Margin: Finding a therapist, Insurance and mental health parity, Cost without insurance, Sliding scale and community clinics, Teletherapy and Waitlists and what to do meanwhile.
The FDA has approved Weltruza, the first once-monthly subcutaneous long-acting injectable olanzapine for adults with schizophrenia, available in three strengths without loading doses.
A gut bacterial compound, imidazole propionate, is linked to faster cognitive decline and higher Alzheimer's disease biomarkers in a study of nearly 1,200 people.
The Trump administration has filed an emergency Supreme Court appeal to enforce a ban on gender-affirming medical treatments in federal prisons.
A new protein interaction map for 100 autism risk genes shows 87% of 1,881 interactions were previously unknown.
A new study in mice identifies brain circuits that become dysregulated during S-ketamine-induced hallucination-like states, separating perception from action.
A large Swedish study finds semaglutide, the drug in Ozempic and Wegovy, is associated with a 21% lower risk of psychiatric hospitalization.
A court battle between insurer CareFirst and Amgen examines whether buying a pending patent application can be used to unfairly extend a drug monopoly.
Adults aged 40 and older performed 12% faster on an executive function test after one month of using a HEPA air purifier at home.
A weekly medical podcast reviews studies on ADHD's link to cardiovascular disease, hospice care disparities, and IV iron for surgical anemia.
Researchers with the Dog Aging Project have identified metabolic patterns in dogs' blood linked to lifespan that closely resemble those found in humans.
Boston University researchers have identified a distinct population of cells in lung veins that becomes active after injury and promotes scar tissue formation.
Voluntary agreements by the Trump administration and HHS Secretary Robert F. Kennedy Jr. To remove synthetic food dyes and reduce insurance prior authorization are largely unenforced and behind schedule. A KFF Health News report finds deadlines extended and few companies complying, with critics calling the initiatives publicity stunts.
The Centers for Disease Control and Prevention (CDC) has been left with 'zombie programs' due to the Trump administration's layoffs, which have resulted in a lack of staffing and expertise in key areas. The programs, which were funded by Congress, are still on the books but are not being implemented due to the lack of personnel.
The Trump administration has announced that Medicaid will stop paying for gender-affirming surgeries and hormone treatments for transgender minors, effective October 13.
Recent research suggests that the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy may not pose significant risks when the effects of the medication are separated from the underlying psychiatric conditions. Experts emphasize the importance of structured decision-making and patient education to address concerns about maternal and fetal health.